Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

78,145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Post-translational modifications of soluble α-synuclein regulate the amplification of pathological α-synuclein.
Zhang S, Zhu R, Pan B, Xu H, Olufemi MF, Gathagan RJ, Li Y, Zhang L, Zhang J, Xiang W, Kagan EM, Cao X, Yuan C, Kim SJ, Williams CK, Magaki S, Vinters HV, Lashuel HA, Garcia BA, James Petersson E, Trojanowski JQ, Lee VM, Peng C. Zhang S, et al. Among authors: zhang l, zhang j. Nat Neurosci. 2023 Feb;26(2):213-225. doi: 10.1038/s41593-022-01239-7. Epub 2023 Jan 23. Nat Neurosci. 2023. PMID: 36690898 Free PMC article.
Author Correction: Post-translational modifications of soluble α-synuclein regulate the amplification of pathological α-synuclein.
Zhang S, Zhu R, Pan B, Xu H, Olufemi MF, Gathagan RJ, Li Y, Zhang L, Zhang J, Xiang W, Kagan EM, Cao X, Yuan C, Kim SJ, Williams CK, Magaki S, Vinters HV, Lashuel HA, Garcia BA, James Petersson E, Trojanowski JQ, Lee VM, Peng C. Zhang S, et al. Among authors: zhang l, zhang j. Nat Neurosci. 2023 Dec;26(12):2250. doi: 10.1038/s41593-023-01474-6. Nat Neurosci. 2023. PMID: 37814027 No abstract available.
A phase 1 study to assess the absolute bioavailability, mass balance, pharmacokinetics, metabolism, and excretion of [14C]-mobocertinib, an oral inhibitor of EGFR exon 20 insertion mutations, in healthy participants.
Hanley MJ, Zhang S, Griffin R, Zhu SX, Fram RJ, Lin J, Venkatakrishnan K, Gupta N. Hanley MJ, et al. Among authors: zhang s. Invest New Drugs. 2024 May 24. doi: 10.1007/s10637-024-01446-y. Online ahead of print. Invest New Drugs. 2024. PMID: 38789848
Efficacy and safety of Ferrous iron on the prevention of Vascular cOgnitive impaiRment among patients with cerebral Infarction/TIA (FAVORITE): rationale and design of a multicentre randomised trial.
Jia Q, Lei P, Sun L, Jia WL, Pan Y, Yuan B, Wang Y, Zhou Q, Meng X, Jing J, Lin J, Wang A, Zhang S, Hong Z, Yang Y, Xiong Y, Li Z, Wang Y, Zhao X, Wang Y. Jia Q, et al. Among authors: zhang s. Stroke Vasc Neurol. 2024 May 24:svn-2023-002644. doi: 10.1136/svn-2023-002644. Online ahead of print. Stroke Vasc Neurol. 2024. PMID: 38789134
78,145 results
You have reached the last available page of results. Please see the User Guide for more information.